XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
Clinical trial NCT00226668 · WITHDRAWN
Trial details
- NCT number
- NCT00226668
- Sponsor
- Celtic Pharma Development Services
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.